Diaceutics (LON:DXRX) Earns “Buy” Rating from Canaccord Genuity Group

Canaccord Genuity Group reissued their buy rating on shares of Diaceutics (LON:DXRX) in a research note released on Tuesday, Marketbeat.com reports. Canaccord Genuity Group currently has a GBX 150 ($1.91) price target on the stock.

Diaceutics Price Performance

Shares of LON DXRX opened at GBX 127.50 ($1.62) on Tuesday. The company has a debt-to-equity ratio of 3.07, a quick ratio of 9.92 and a current ratio of 7.99. Diaceutics has a fifty-two week low of GBX 79 ($1.00) and a fifty-two week high of GBX 129 ($1.64). The firm has a market capitalization of £107.97 million, a PE ratio of 10,500.00 and a beta of 0.47. The stock’s 50-day simple moving average is GBX 104.65 and its 200-day simple moving average is GBX 96.90.

Insider Transactions at Diaceutics

In other Diaceutics news, insider Graham Paterson bought 33,564 shares of the business’s stock in a transaction dated Wednesday, March 6th. The shares were acquired at an average price of GBX 99 ($1.26) per share, with a total value of £33,228.36 ($42,232.28). In other news, insider Peter Keeling sold 750,000 shares of the firm’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of GBX 102 ($1.30), for a total transaction of £765,000 ($972,292.83). Also, insider Graham Paterson bought 33,564 shares of the business’s stock in a transaction dated Wednesday, March 6th. The shares were acquired at an average cost of GBX 99 ($1.26) per share, for a total transaction of £33,228.36 ($42,232.28). Corporate insiders own 34.54% of the company’s stock.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.